Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-16

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a generic Mirtazapine product from Aurobindo Pharma Limited, enabling continued marketing of an approved generic ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)